We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
+11.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$21.1M
Cap. Flow
+$10.8M
Cap. Flow %
0.83%
Top 10 Hldgs %
44%
Holding
310
New
3
Increased
19
Reduced
69
Closed
48

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.76M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.74M
3
HON icon
Honeywell
HON
+$1.53M
4
MA icon
Mastercard
MA
+$1.22M
5
JPM icon
JPMorgan Chase
JPM
+$1.19M

Sector Composition

Rank Sector Weight
1 Industrials 21.18%
2 Financials 20.56%
3 Technology 18.47%
4 Consumer Discretionary 15.51%
5 Healthcare 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIST icon
301
Vista Energy
VIST
$7.42B
-22
Closed -$757
WSC icon
302
WillScot Mobile Mini Holdings
WSC
$4.85B
-10
Closed -$212
WSM icon
303
Williams-Sonoma
WSM
$27.6B
-2,144
Closed -$419K
XPEL icon
304
XPEL
XPEL
$1.18B
-10
Closed -$331
ZIMV
305
DELISTED
ZimVie
ZIMV
-60
Closed -$1.14K
SOLV icon
306
Solventum
SOLV
$13.9B
-150
Closed -$10.9K
NMAX
307
Newsmax Inc
NMAX
$998M
-300
Closed -$3.72K

Similar funds

Kimelman & Baird's Q4 2025 Portfolio in Review

As of Q4 2025, Kimelman & Baird held 310 positions worth $1.3B, up 1.7% from $1.28B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Kimelman & Baird's Q4 2025 filing shows 3 new, 19 increased, 69 reduced and 48 closed positions. Its largest new stake was Solstice Advanced Materials: 28,495 shares worth $1.38M. The largest sale was Eli Lilly, an estimated $1.76M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Technology.

  • Kimelman & Baird's largest Q4 2025 buy was Solstice Advanced Materials: 28,495 shares worth $1.38M.
  • Kimelman & Baird added most to Boeing in Q4 2025, an estimated $24M increase.
  • Kimelman & Baird's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $1.76M.
  • Kimelman & Baird fully exited Williams-Sonoma in Q4 2025, selling an estimated $419K.
  • Kimelman & Baird's ten largest holdings make up 44% of its $1.3B portfolio in Q4 2025.
  • Kimelman & Baird opened 3 new positions and closed 48 in Q4 2025.
  • Kimelman & Baird's portfolio value rose 1.7% quarter-over-quarter to $1.3B.

Based on Kimelman & Baird's 13F filing for Q4 2025, filed 6 Feb 2026.